Real-time enrollment status for this metastatic triple-negative breast carcinoma clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 2:20 AM UTC
| NCT Number | NCT06008275 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Triple-Negative Breast Carcinoma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Baylor Research Institute |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of September 2, 2026: Clinical trial NCT06008275 is currently recruiting participants. This early_phase1 study for metastatic triple-negative breast carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Baylor Research Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06008275 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06008275 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.